Crossmark

Comparison of Relative Activity versus Relative Expression Factors (RAF versus REF) in Predicting Glucuronidation Mediated Drug Clearance Using Recombinant UGTs

Crossref DOI link: https://doi.org/10.1007/s11095-024-03750-x

Published Online: 2024-08-06

Published Print: 2024-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Subash, Sandhya

Ahire, Deepak

Patel, Mitesh

Shaikh, Sahil

Singh, Dilip Kumar

Deshmukh, Sujal

Prasad, Bhagwat
Funding

Funding for this research was provided by:

Novartis Institutes for BioMedical Research
License Information

Text and Data Mining valid from 2024-08-01

Version of Record valid from 2024-08-01
More Information

Article History

Received: 23 April 2024

Accepted: 18 July 2024

First Online: 6 August 2024

Declarations

:

: BP is cofounder of Precision Quantomics Inc. and recipient of research funding from Bristol Myers Squibb, Genentech, Gilead, Merck, Novartis, Takeda, and Generation Bio. All other authors declared no competing interests for this work.

Document is current

Any future updates will be listed below